dismiss

Clean Sweep Live Auction on Wed. May 1st. Click to view the full inventory

DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Pediatrics
SEARCH
Aktueller Standort:
>
> This Story


Log in oder Register to rate this News Story
Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

Alzheimers/Neurology Homepage

PET uncovers abnormal tau deposits associated with CTE in live subjects May enable diagnosis of CTE in living people one day

New study shows value of 7T MR for evaluating MS progression Can detect cortical lesions better than conventional scanners

Amyloid PET scans help with Alzheimer's clinical management New insights from the 11,000 patient IDEAS study

Women's brains appear three years younger than men's at the same age: PET study A machine-learning algorithm assisted with the analysis

APRINOIA and Celgene partner on promising PET tracer APN-1607 holds potential for visualizing tau pathology in diverse tauopathies

Opening blood brain barrier, focused ultrasound is closing therapy gap Insights from the 6th International Symposium on Focused Ultrasound

Stryker inks two partnerships for enhanced surgical guidance Offering whole-brain tractography and detail-rich imaging

NuVasive to offer intraoperative neuromonitoring services to Premier clientele Reduces surgical risk for full range of procedures

FDA okays Insightec's MR-guided focused ultrasound with Siemens scanners Using Exablate Neuro for treating essential tremor

Cerveau Technologies partners with Ionis Pharmaceuticals Use of PET agent, [F-18]MK-6240

May lead to development of new
treatment drugs

SNMMI 2016: Groundbreaking PET/CT study finds specific brain receptor linked to alcohol addiction

by John W. Mitchell , Senior Correspondent
Alcoholism is a disorder that oftentimes leads to a continuous cycle of abuse. However, a new study revealed that using PET/CT to understand the connection between the mGluR5 brain receptor associated with reward and pleasure and the compulsion to drink may be the solution to long-term sobriety.

“This research is the first to provide direct in vivo evidence that mGluR5 is involved in the pathophysiology of alcohol addiction,” Dr. Gil Leurquin-Sterk, first author of the study and physician at the University Hospital Gasthuisberg in Leuven, Belgium, told HCB News. “Before this development, direct human evidence of its involvement in addiction was lacking and only suggested by animal models.”

Story Continues Below Advertisement

Servicing GE Nuclear Medicine equipment with OEM trained engineers

We offer full service contracts, PM contracts, rapid response, time and material,camera relocation. Nuclear medicine equipment service provider since 1975. Click or call now for more information 800 96 NUMED



About seven percent of adults over the age of 18 have a drinking disorder, according to the National Institute on Alcohol Abuse and Alcoholism. Alcohol-related deaths were deemed the fourth leading cause of preventable death, accounting for about 88,000 deaths annually in the U.S.

“Alcohol addiction is a complex, chronic brain disorder associated with enormous physical, social and financial consequences,” said Dr. Koen Van Laere, senior author of the study. “Our team was able to investigate, for the first time, these marked changes in the brain circuitry of alcohol-dependent humans.”

For the study, the researchers used PET/CT with the new PET F-18 FPEB imaging agent that binds to mGluR5. It was administered to 16 recently sober subjects, ranging from age 32 to 57 and 32 healthy control subjects with no history of alcoholism.

The results demonstrated a significant reduction in mGluR5 “availability” in the alcohol-dependent subjects compared to the control group, regardless of age, gender or smoking status.

These findings may help researchers develop new treatment drugs that limit receptor activity in patients who are at risk of relapsing. Leurquin-Sterk explained that mGluR5 antagonists could be effective in reducing craving upon alcohol withdrawal, which is in turn expected to reduce relapse.

"Collectively, these findings strongly substantiate the development of mGluR5-targeted therapies that heal or protect against the dysfunctional brain circuitry that characterizes alcohol addiction," said Gil Leurquin-Sterk.

Alzheimers/Neurology Homepage


You Must Be Logged In To Post A Comment

Werben
Erhöhen Sie Ihren Bekanntheitsgrad
Auktionen + Privatverkäufe
Den besten Preis erzielen
Geräte/Geräteteile kaufen
Den günstigsten Preis finden
Daily News
Die neuesten Nachrichten lesen
Übersicht
Alle DOTmed Benutzer durchsuchen
Ethik auf DOTmed
Unseren Ethik-Standard anzeigen
Gold-Parts Verkäufer-Programm
PH-Anfragen erhalten
Gold Service Dealer-Programm
Anfragen empfangen
Gesundheitsdienstleister
Alle Gesundheitsdienstleister-Tools anzeigen
Jobs/Training
Einen Job suchen
Parts Hunter +EasyPay
Angebote für Geräteteile erhalten
Kürzlich zertifiziert
Kürzlich zertifizierte Benutzer anzeigen
Kürzlich bewertet
Kürzlich zertifizierte Benutzer anzeigen
Rental Central
Geräte billiger mieten
Geräte/Geräteteile verkaufen
Das meiste Geld erhalten
Service-Techniker Forum
Hilfe und Beratung finden
Einfache Angebots-Anfrage
Angebote für Geräte erhalten
Virtuelle Messe
Service für Geräte finden
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2019 DOTmed.com, Inc.
ALL RIGHTS RESERVED